International Assets Investment Management, LLC Veracyte, Inc. Transaction History

International Assets Investment Management, LLC

$1.2 Trillion
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Oct 04, 2023	BUY	$22.33 - $29.92 $37,469 - $50,205	1,678 New	1,678 $37,000
Q1 2023 Apr 19, 2023	BUY	$20.58 - $27.89 $41,077 - $55,668	1,996 New	1,996 $44,000

Others Institutions Holding VCYT

# of Institutions

311

Shares Held

81.6M

Call Options Held

134K

Put Options Held

13.3K

Black Rock Inc. New York, NY

7.79M
Shares

$316 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

7.75M
Shares

$314 Million
0.0% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

5.02M
Shares

$204 Million
0.27% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

4.92M
Shares

$200 Million
1.59% of portfolio
Wellington Management Group LLP Boston, MA

4.23M
Shares

$172 Million
0.03% of portfolio

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.9B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.

Account